check with a healthcare professional if you are under 18, pregnant, or nursing a baby, or if you have any known or suspected medical conditions or have a prescription or OTC medication(s)
This approach minimizes gastrointestinal side effects, which are the most common complaint among new users
Obesity no
Pharmacy teams should rely on program requirements and prescriber documentation rather than determining eligibility at the pharmacy counter Key details Program timeframe: July 1, 2026, through December 31, 2027 Eligible population: Medicare Part D beneficiaries enrolled in an eligible prescription drug plan who meet CMS eligibility criteria, including the programs clinical requirements for weight management
More and more people are turning to medications like Ozempic, Wegovy, Mounjaro, and Zepbound to help manage appetite and support weight loss
It is tested using recombinant GLP-1, as well as several GLP-1R agonists